Biomimetic hydroxyapatite paste for molar-incisor hypomineralization: A randomized clinical trial

Oral Dis. 2023 Oct;29(7):2789-2798. doi: 10.1111/odi.14388. Epub 2022 Oct 4.

Abstract

Objectives: The aim of this randomized clinical trial was to evaluate the desensitizing and remineralizing effect of a new zinc-hydroxyapatite-based paste in sites affected by molar-incisor hypomineralization (MIH), by assessing dental sensitivity, tooth wear, and periodontal indexes.

Materials and methods: Twenty-five patients with presence of 1 enamel demineralization of permanent molars and incisors in two different quadrants were recruited. After professional dental hygiene, a domiciliary hydroxyapatite-based paste was assigned and recommended to be applied on 2 MIH teeth in one random quadrant (test group), while the 2 contralateral MIH teeth did not undergo paste application (control group). The following primary outcomes were assessed: Plaque Control Record (PCR), Bleeding Index (BI), MIH Treatment Need Index (MIH-TNI), and Schiff Air Index (SAI).

Results: No significant inter- and intragroup differences were found for PI and BI, except for both intragroup T0-T1. For MIH-TNI, significant intergroup differences were detectable in the test group after 9 months of treatment. For SAI values, no significant differences were found in the control group, while in the test group, significant lower values were found after 1 and 3 months since baseline, respectively.

Conclusions and clinical relevance: Biomimetic zinc-hydroxyapatite showed a desensitizing effect when used to treat MIH.

Keywords: biomimetic hydroxyapatite; demineralization; enamel; molar-incisor hypomineralization; paste; randomized clinical trial.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Biomimetics
  • Dental Enamel Hypoplasia* / drug therapy
  • Humans
  • Hydroxyapatites
  • Molar
  • Molar Hypomineralization*
  • Prevalence

Substances

  • Hydroxyapatites